The document discusses media monitoring services for pharmaceutical companies. It provides an overview of how specialized media, online sources, blogs and social sites can be monitored to track mentions of drugs, companies, competitors' actions and reports of side effects. The monitoring process involves collecting data from various medical and pharmaceutical print and online sources, converting it to a digital database, and providing clients with a final report and access to all relevant articles. Metrics such as the number of mentions and distribution across media types are also reported to clients.

1. Medical and pharmaceutical specialized printed media, on-line media, blogs, social sites, etc. monitoring Bekunis Search period: 01.01.2011 – 01.05.2011 Pharmacovigilance

2. Information about the side effects of drugs, the mention of the company, competitors' actions, etc. is very important for conducting business activity and decision-making. Speed ​​and quality of services will save you time and provide you with the maximal amount of information.

3. Search and tracking information using special tools enable to monitor specialized medical and pharmaceutical printed media, online mass media, forums, social networks, microblogging, presentations and videos

4. Let’s see a real case of media monitoring. In this example we’ll show the process and the results of monitoring for such drug as Bekunis

5. Process of collecting and processing initial data and monitoring printed media Medical and pharmaceutical specialized printed media CONVERSION Digital database Request Final report with all list of mentions of a drug or a company and possibility to view each article included in report

6. Internet sources monitoring process Search options Here you can view all articles in on-line media where Bekunis is mentioned Number of mentions for Bekunis found during period of search

7. The dynamic of mentions by the types of media The distribution of mentions by the types of media

8. time saving; reasonable price of the service; receiving important information about: promotional activities of competitors; mentions of the company in mass media with an estimation of publication tonality; publications with mention of side effects of drugs